Rural Health
Resources by Topic: Pharmacy and prescription drugs
Community Pharmacies in Wisconsin
Map showing actively-licensed, community pharmacies in Wisconsin counties. Includes locations for chain pharmacies, independent pharmacies, and clinic/outpatient/HMO pharmacies based on data from October 2019.
Date: 04/2020
Sponsoring organizations: University of Wisconsin Madison School of Pharmacy, Wisconsin Office of Rural Health
view details
Map showing actively-licensed, community pharmacies in Wisconsin counties. Includes locations for chain pharmacies, independent pharmacies, and clinic/outpatient/HMO pharmacies based on data from October 2019.
Date: 04/2020
Sponsoring organizations: University of Wisconsin Madison School of Pharmacy, Wisconsin Office of Rural Health
view details
MedPAC Report to the Congress: Medicare Payment Policy, 2020
Annual review of Medicare payment policies, with recommendations to Congress. Includes discussion on Medicare payment policies directly affecting rural providers and beneficiaries. Addresses payment adequacy for healthcare facilities and services, improving Medicare payment for post-acute care, Medicare Advantage, Medicare Part D, and the impact of healthcare provider consolidation.
Date: 03/2020
Sponsoring organization: Medicare Payment Advisory Commission
view details
Annual review of Medicare payment policies, with recommendations to Congress. Includes discussion on Medicare payment policies directly affecting rural providers and beneficiaries. Addresses payment adequacy for healthcare facilities and services, improving Medicare payment for post-acute care, Medicare Advantage, Medicare Part D, and the impact of healthcare provider consolidation.
Date: 03/2020
Sponsoring organization: Medicare Payment Advisory Commission
view details
Exploring Opportunities to Leverage Pharmacists in Rural Areas to Promote Administration of Human Papillomavirus Vaccine
Describes the role of rural pharmacists in promoting and administering the human papillomavirus (HPV) vaccine using information gathered from interviews of 11 pharmacists at independently owned pharmacies in Iowa. Identifies factors facilitating the administration and accessibility of the vaccine and reports on personal barriers regarding safety, lack of information, and staff capacity.
Author(s): Grace Ryan, Eliza Daly, Natoshia Askelson, et al.
Citation: Preventing Chronic Disease, 17
Date: 03/2020
view details
Describes the role of rural pharmacists in promoting and administering the human papillomavirus (HPV) vaccine using information gathered from interviews of 11 pharmacists at independently owned pharmacies in Iowa. Identifies factors facilitating the administration and accessibility of the vaccine and reports on personal barriers regarding safety, lack of information, and staff capacity.
Author(s): Grace Ryan, Eliza Daly, Natoshia Askelson, et al.
Citation: Preventing Chronic Disease, 17
Date: 03/2020
view details
Availability of Naloxone at Rural Georgia Pharmacies, 2019
Research letter describing a study of 374 rural Georgia pharmacies. Examines pharmacists' awareness of the Georgia law allowing purchase of naloxone without a prescription, and availability and cost of the medicine.
Author(s): Jennifer L. Nguyen, Lauren R. Gilbert, Lauren Beasley, et al.
Citation: JAMA Network Open, 3(2)
Date: 02/2020
view details
Research letter describing a study of 374 rural Georgia pharmacies. Examines pharmacists' awareness of the Georgia law allowing purchase of naloxone without a prescription, and availability and cost of the medicine.
Author(s): Jennifer L. Nguyen, Lauren R. Gilbert, Lauren Beasley, et al.
Citation: JAMA Network Open, 3(2)
Date: 02/2020
view details
340B Drug Discount Program: Oversight of the Intersection with the Medicaid Drug Rebate Program Needs Improvement
Examines state and federal efforts to prevent duplicate discounts under the 340B and Medicaid Drug Rebate Programs and identifies limitations and weaknesses in federal oversight. Provides recommendations to the Centers for Medicare and Medicaid Services and the Health Resources and Services Administration to strengthen oversight of these programs.
Additional links: Full Report
Date: 01/2020
Sponsoring organization: Government Accountability Office
view details
Examines state and federal efforts to prevent duplicate discounts under the 340B and Medicaid Drug Rebate Programs and identifies limitations and weaknesses in federal oversight. Provides recommendations to the Centers for Medicare and Medicaid Services and the Health Resources and Services Administration to strengthen oversight of these programs.
Additional links: Full Report
Date: 01/2020
Sponsoring organization: Government Accountability Office
view details
Trends in Opioids Prescribed at Discharge From Emergency Departments Among Adults: United States, 2006–2017
Examines trends in emergency department (ED) discharge opioid prescribing for adults from 2006–2007 through 2016–2017. Provides data by selected patient and hospital characteristics and the type of opioids prescribed. Table 1 includes data on the percent of ED patients prescribed an opioid at discharge by location of patient residence for metropolitan and nonmetropolitan areas.
Author(s): Pinyao Rui, Loredana Santo, Jill J. Ashman
Date: 01/2020
Sponsoring organization: National Center for Health Statistics
view details
Examines trends in emergency department (ED) discharge opioid prescribing for adults from 2006–2007 through 2016–2017. Provides data by selected patient and hospital characteristics and the type of opioids prescribed. Table 1 includes data on the percent of ED patients prescribed an opioid at discharge by location of patient residence for metropolitan and nonmetropolitan areas.
Author(s): Pinyao Rui, Loredana Santo, Jill J. Ashman
Date: 01/2020
Sponsoring organization: National Center for Health Statistics
view details
Acceptability of Buprenorphine as A Treatment for Opioid Use Disorders: Experiences of Health Providers In Indiana Rural Counties
Slides from a presentation at the 2020 American Public Health Association conference focused on utilizing buprenorphine for Medication Assisted Treatment (MAT). Examines 29 semi-structured interviews of medical and non-medical professionals from rural counties in Indiana about barriers and facilitators of buprenorphine use.
Author(s): Josephine Mwangi
Date: 2020
Sponsoring organization: Indiana University Bloomington
view details
Slides from a presentation at the 2020 American Public Health Association conference focused on utilizing buprenorphine for Medication Assisted Treatment (MAT). Examines 29 semi-structured interviews of medical and non-medical professionals from rural counties in Indiana about barriers and facilitators of buprenorphine use.
Author(s): Josephine Mwangi
Date: 2020
Sponsoring organization: Indiana University Bloomington
view details
The Rural Health Care Coordination Network Partnership Program: Avera St. Mary's Completing the Circle Project
Describes and examines the impact of a care coordination program developed by Avera St. Mary's located in Pierre, South Dakota. Used a Patient Centered Medical Home (PCMH) model, providing services to patients with type 2 diabetes. The program's care team connected patients to resources and coordinated the patient's primary care providers, medications, specialists, other health care services, and a variety of social services. Funded under the Rural Health Care Coordination Network Partnership Grant Program from 2015-2018.
Date: 2020
Sponsoring organizations: NORC Walsh Center for Rural Health Analysis, University of Minnesota Rural Health Research Center
view details
Describes and examines the impact of a care coordination program developed by Avera St. Mary's located in Pierre, South Dakota. Used a Patient Centered Medical Home (PCMH) model, providing services to patients with type 2 diabetes. The program's care team connected patients to resources and coordinated the patient's primary care providers, medications, specialists, other health care services, and a variety of social services. Funded under the Rural Health Care Coordination Network Partnership Grant Program from 2015-2018.
Date: 2020
Sponsoring organizations: NORC Walsh Center for Rural Health Analysis, University of Minnesota Rural Health Research Center
view details
Opioid Prescribing Among Adults With Disabilities in the United States After the 2014 Federal Hydrocodone Rescheduling Regulation
Examines the impact of the 2014 federal rescheduling regulation regarding hydrocodone-combination products on Medicare beneficiaries with disabilities. Provides maps of prolonged opioid use by Medicare beneficiaries with disabilities by state before and after the regulation was implemented. Includes data analysis of beneficiaries in metropolitan, urban, and rural areas.
Author(s): Victor Law, Yong-Fang Kuo, Mukaila A. Raji, Jacques Baillargeon
Citation: Public Health Reports, 135(1), 114-123
Date: 12/2019
view details
Examines the impact of the 2014 federal rescheduling regulation regarding hydrocodone-combination products on Medicare beneficiaries with disabilities. Provides maps of prolonged opioid use by Medicare beneficiaries with disabilities by state before and after the regulation was implemented. Includes data analysis of beneficiaries in metropolitan, urban, and rural areas.
Author(s): Victor Law, Yong-Fang Kuo, Mukaila A. Raji, Jacques Baillargeon
Citation: Public Health Reports, 135(1), 114-123
Date: 12/2019
view details
340B Drug Discount Program: Increased Oversight Needed to Ensure Nongovernmental Hospitals Meet Eligibility Requirements
Provides an overview of the Government Accountability Office's (GAO) review of 258 nongovernmental hospitals that participate in the 340B Drug Pricing Program and their contracts with state and local governments. Evaluates the contracts to determine if they meet the eligibility requirement to serve low-income individuals. Outlines weaknesses in the Health Resources and Services Administration's review of the hospital contracts and offers six recommendations to improve the contract review process.
Additional links: Full Report
Date: 12/2019
Sponsoring organization: Government Accountability Office
view details
Provides an overview of the Government Accountability Office's (GAO) review of 258 nongovernmental hospitals that participate in the 340B Drug Pricing Program and their contracts with state and local governments. Evaluates the contracts to determine if they meet the eligibility requirement to serve low-income individuals. Outlines weaknesses in the Health Resources and Services Administration's review of the hospital contracts and offers six recommendations to improve the contract review process.
Additional links: Full Report
Date: 12/2019
Sponsoring organization: Government Accountability Office
view details